Active Ingredient
Salicylic Acid 2.0%
The following Structured Product Label (SPL) was submitted to the FDA by Banuskin, Inc. for the product Aha Bha Blemish Control And Exfoliating Serum (NDC 85439-0101). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, when using this product, keep out of reach of children., direction, other information, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Salicylic Acid 2.0%
Acne Treatment
For the treatment of acne
For external use only
When using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin's sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards.
Aqua/Water/Eau, Isopentyldiol, Squalane, Dipropylene Glycol, Hydroxypropyl Starch Phosphate, Mandelic Acid, Niacinamide, Sodium Hydroxide, Citric Acid, Succinic Acid, Phenoxyethanol, Lactobacillus ferment lysate, Xanthan Gum, Alpha-glucan oligosaccharide, Hydrogenated Lecithin, Sclerotium Gum, Lecithin, Pullulan, Allantoin, Bisabolol, Sodium Phytate, Potassium Sorbate, Sodium Benzoate, Silica, 1,2-Hexanediol, Hydroxyacetophenone, Sodium Hyaluronate, Ethylhexylglycerin.
Questions or comments?
www.banuskin.com
855-215-2268
Topical Liquid (Serum)
banu
AHA + BHA BLEMISH CONTROL & EXFOLIATING SERUM
2% Salicylic Acid
Acne Treatment
SAFE FOR ACNE-PRONE SKIN
30 mL/1 fl.oz
* Please review the disclaimer below.